Avoro Capital Advisors LLC Argenx Se Transaction History
Avoro Capital Advisors LLC
- $5.48 Billion
- Q2 2025
A detailed history of Avoro Capital Advisors LLC transactions in Argenx Se stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 1,175,000 shares of ARGX stock, worth $889 Million. This represents 11.81% of its overall portfolio holdings.
Number of Shares
1,175,000
Previous 1,235,177
4.87%
Holding current value
$889 Million
Previous $731 Million
11.41%
% of portfolio
11.81%
Previous 11.83%
Shares
23 transactions
Others Institutions Holding ARGX
# of Institutions
491Shares Held
28.3MCall Options Held
370KPut Options Held
211K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$3.77 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$2.11 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.57MShares$1.94 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.48 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$765 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $41.8B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...